Faculty profile

Keyue Ding

Back to faculty

Associate ProfessorDepartment of Public Health SciencesQueen's University

Keyue Ding

Associate Professor

Department of Public Health Sciences

Queen's University

Kingston, Ontario, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
13 publications in the last five years, latest in 2026.
Principal investigator on 2 research grants (2 NSERC), most recently in 2008.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

2,857

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

iDORCID OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their Queen's University profile.

Latest papers

Long-term patient-reported outcomes in a randomized controlled trial of Mepitel Film versus standard of care for the prevention of acute breast radiation dermatitis
Breast Cancer Research and Treatment · 2026
Nomograms for predicting survival of elderly patients with newly diagnosed glioblastoma: a secondary analysis of the CCTG CE.6 trial.
Journal of neuro-oncology · 2026
Adjuvant Durvalumab in Completely Resected Early-Stage Non-Small Cell Lung Cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2026

All 51 publications

Latest funding

TRIPLE-SWITCH: A Randomized Clinical Trial for the Addition of Docetaxel to Androgen Receptor Pathway Inhibitors (ARPI) and Androgen Deprivation Treatment (ADT) in Patients with Metastatic Castration-Sensitive Prostate Cancer (mCSPC) and Suboptimal PSA Response.
CIHR · 2024 · Co-investigator
$2,487,015
Predictive biomarkers for adjuvant immune checkpoint inhibitor therapy in non-small cell lung cancer
CIHR · 2022 · Co-investigator
$1,224,000
Cox regression model with change-point(s) problems and their application in cancer drug development
NSERC · 2008 · Principal investigator
$70,000

All 4 grants and awards

51 publications.

Long-term patient-reported outcomes in a randomized controlled trial of Mepitel Film versus standard of care for the prevention of acute breast radiation dermatitis

Bayrakdarian S, Hircock C, Wong HCY, Zhang L, Ding K, Karam I, Gallant F, Rakovitch E, Tran W, Soliman H

Breast Cancer Research and Treatment2026

DOI: 10.1007/s10549-026-07987-5

Nomograms for predicting survival of elderly patients with newly diagnosed glioblastoma: a secondary analysis of the CCTG CE.6 trial.

Moraes FY, Isen J, Perry J, Laperriere N, Brandes AA, Menten J, Phillips C, Fay M, Nishikawa R, Mason WP, Cairncross JG, Roa W, Ding K, O'Callaghan C

Journal of neuro-oncology2026

DOI: 10.1007/s11060-025-05399-x PMID: 41553596

Adjuvant Durvalumab in Completely Resected Early-Stage Non-Small Cell Lung Cancer.

Goss GD, Darling GE, Westeel V, Nakagawa K, Massutí B, Perrone F, McLachlan SA, Kang JH, Wu YL, Dingemans AC, Dziadziuszko R, Greillier L, Okada M, Audigier-Valette C, Sugawara S, Nadal E, Catino A, Toffart AC, Mitsudomi T, Whittom R, Domine M, Yamamoto N, Molinier O, Morin F, Bradbury PA, Stockler MR, Ding K, O'Callaghan CJ

Journal of clinical oncology : official journal of the American Society of Clinical Oncology2026

DOI: 10.1200/jco-25-01828 PMID: 41529222

Correction to: Nomograms for predicting survival of elderly patients with newly diagnosed glioblastoma: a secondary analysis of the CCTG CE.6 trial.

Moraes FY, Isen J, Perry J, Laperriere N, Brandes AA, Menten J, Phillips C, Fay M, Nishikawa R, Mason WP, Cairncross JG, Roa W, Ding K, O'Callaghan C

Journal of neuro-oncology2026

DOI: 10.1007/s11060-026-05442-5 PMID: 41661466

Effects of serotonergic drugs on immune checkpoint inhibitor response: a pooled analysis of individual patient data from four Canadian Cancer Trials Group (CCTG) trials

Coschi CH, Ding K, Tu D, O’Callaghan C, Leighl NB, Vera-Badillo F, Juergens RA, Hao D, Seymour L, Renouf DJ

Immunotherapy2025

DOI: 10.1080/1750743x.2025.2578164

An Economic Analysis of SC24 in Canada: A Randomized Study of SBRT Compared With Conventional Palliative RT for Spinal Metastases.

Kerba M, Lourenco RA, Sahgal A, Cardet RF, Siva S, Ding K, Myrehaug SD, Masucci GL, Brundage M, Parulekar WR

International journal of radiation oncology, biology, physics20246 citations

DOI: 10.1016/j.ijrobp.2023.12.052 PMID: 38218455

Benefit of adjuvant chemotherapy for resected pathologic N1 non-small cell lung cancer is unrecognized: A subgroup analysis of the JBR10 trial.

Toubat O, Ding L, Ding K, Wightman SC, Atay SM, Harano T, Kim AW, David EA

Seminars in thoracic and cardiovascular surgery2024

DOI: 10.1053/j.semtcvs.2022.10.005 PMID: 36272526

Correlation of CTCAE and patient-reported breast radiation dermatitis symptom scores.

Rajeswaran T, Gojsevic M, Zhang L, Kennedy SKF, Karam I, Ding K, Herst P, Wong H, Kwan JYY, Safavi AH, Lam J, Spadafora S, Walde N, Carothers K, Gallant F, Behroozian T, Lam E, Chow E

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2024

DOI: 10.1007/s00520-024-09018-9 PMID: 39556198

Concordance of patient- and clinician-reported outcomes of acute radiation dermatitis in breast cancer.

Gojsevic M, Rajeswaran T, Zhang L, Kennedy SKF, Karam I, Ding K, Herst P, Wong H, Kwan JYY, Safavi AH, Lam J, Spadafora S, Walde N, Carothers K, Gallant F, Behroozian T, Lam E, Chow E

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2024

DOI: 10.1007/s00520-024-08966-6 PMID: 39495339

ctDNA response after pembrolizumab in non-small cell lung cancer: phase 2 adaptive trial results

Anagnostou V, Ho C, Nicholas G, Juergens RA, Sacher A, Fung AS, Wheatley-Price P, Laurie SA, Levy B, Brahmer JR

Nature Medicine2023175 citationsOpen Access

DOI: 10.1038/s41591-023-02598-9

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Keyue Ding

Research

Latest papers

Latest funding

Long-term patient-reported outcomes in a randomized controlled trial of Mepitel Film versus standard of care for the prevention of acute breast radiation dermatitis

Nomograms for predicting survival of elderly patients with newly diagnosed glioblastoma: a secondary analysis of the CCTG CE.6 trial.

Adjuvant Durvalumab in Completely Resected Early-Stage Non-Small Cell Lung Cancer.

Correction to: Nomograms for predicting survival of elderly patients with newly diagnosed glioblastoma: a secondary analysis of the CCTG CE.6 trial.

Effects of serotonergic drugs on immune checkpoint inhibitor response: a pooled analysis of individual patient data from four Canadian Cancer Trials Group (CCTG) trials

An Economic Analysis of SC24 in Canada: A Randomized Study of SBRT Compared With Conventional Palliative RT for Spinal Metastases.

Benefit of adjuvant chemotherapy for resected pathologic N1 non-small cell lung cancer is unrecognized: A subgroup analysis of the JBR10 trial.

Correlation of CTCAE and patient-reported breast radiation dermatitis symptom scores.

Concordance of patient- and clinician-reported outcomes of acute radiation dermatitis in breast cancer.

ctDNA response after pembrolizumab in non-small cell lung cancer: phase 2 adaptive trial results

TRIPLE-SWITCH: A Randomized Clinical Trial for the Addition of Docetaxel to Androgen Receptor Pathway Inhibitors (ARPI) and Androgen Deprivation Treatment (ADT) in Patients with Metastatic Castration-Sensitive Prostate Cancer (mCSPC) and Suboptimal PSA Response.

Predictive biomarkers for adjuvant immune checkpoint inhibitor therapy in non-small cell lung cancer

Cox regression model with change-point(s) problems and their application in cancer drug development

Meta-analysis of sequential clinical trials

Frequent collaborators

Edward Chow

Carolyn Wilson

Michael Brundage

Ralph Meyer

Carlo DeAngelis

Joda Kuk

Lesley Seymour

Raimond Wong

Wendy Parulekar

Laurence Klotz

Paul Toren

James Perry

Irene Karam

Juanita Crook

Andrea Bezjak

Ming Tsao

Rebecca Wong

Glenwood Goss

Ming-Sound Tsao

George Charames

Arjun Sahgal

Hany Soliman

Danny Vesprini

Eric Leung

Hanbo Chen

William Tran

Rosalyn Juergens

Neil Fleshner

Geoffrey Liu

Peter Ellis

Chantal Guillemette

Srikala Sridhar

Normand Blais

Patrick Cheung

Pierre-Olivier Gaudreau